ATP release and HMGB1 secretion are considered hallmarks of ICD and thus of effective anti‐tumor immune responses.[41] Here, ATP and HMGB1 were measured by enzyme‐linked immunosorbent assays (ELISAs). This evidence concerns the gene HMGB1 and neoplasm.